- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07735910
Binaural Beats for Cognitive Function in Older Adults With Mild Cognitive Impairment in Nursing Homes (BB-MCI)
July 27, 2026 updated by: Yuhan Geng, China Medical University, China
The Effect of Binaural Beats on Cognitive Function in Older Adults With Mild Cognitive Impairment in Nursing Homes: A Randomized Controlled Trial
This study will evaluate whether binaural beats can improve cognitive function in older adults with mild cognitive impairment living in nursing homes.
Participants will listen to 10-Hz alpha-frequency binaural beats through headphones once daily for 30 minutes for 14 consecutive days.
Cognitive function, sleep quality, anxiety, and depressive symptoms will be assessed before the intervention, after the intervention, and at a 2-week follow-up after the intervention.
The study aims to determine whether binaural beats are a safe, simple, and non-drug approach to support cognitive health in older adults with mild cognitive impairment.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Liu Yu Yu Liu, Professor
- Phone Number: +8618640068209
- Email: liuyu@cmu.edu.cn
Study Locations
-
-
Liaoning
-
Shenyang, Liaoning, China, 110030
- Recruiting
- Jintaiyang Jingguan Elderly Care Apartment
-
Contact:
- Yuhan Geng
- Phone Number: 18018945883
- Email: gengyuhan@cmu.edu.cn
-
Shenyang, Liaoning, China, 110031
- Recruiting
- Jintaiyang Elderly Care Center, Huanggu Branch
-
Contact:
- Yuhan Geng
- Phone Number: 18018945883
- Email: gengyuhan@cmu.edu.cn
-
Shenyang, Liaoning, China, 110042
- Recruiting
- Renai Changwan Elderly Care Home, Dadong District
-
Contact:
- Yuhan Geng
- Phone Number: 18018945883
- Email: gengyuhan@cmu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 60 years or older.
- Not previously diagnosed with dementia.
- Meets the diagnostic criteria for mild cognitive impairment, with Montreal Cognitive Assessment scores adjusted by education level, Mini-Mental State Examination score >= 24, and Activities of Daily Living score < 23.
- Has lived in a nursing home for more than 2 months and plans to continue living there during the study period.
- No hearing impairment; Hearing Handicap Inventory for the Elderly-Screening Version score < 8, and able to hear binaural beats through both ears.
- Conscious and able to cooperate with questionnaires and scale assessments.
- Has not taken medications that may affect cognitive function within 3 to 6 months before the intervention.
Exclusion Criteria:
- Severe physical disease, major organ failure, or advanced malignant tumor.
- Diagnosed depression or other psychiatric disorders.
Withdrawal Criteria:
- Serious adverse events during the study, such as falls, disease recurrence, discomfort caused by the intervention audio, death, or other conditions making continued participation unsuitable.
- Voluntary withdrawal from the study.
Removal Criteria:
- Incomplete data resulting in missing information.
- Missing three or more intervention sessions within 2 weeks without following intervention instructions.
- Receiving other treatments or interventions related to cognitive function during the trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Binaural Beats Plus Old Songs Group
Participants will listen to old songs embedded with 10-Hz alpha-frequency binaural beats through headphones once daily for 30 minutes for 14 consecutive days.
|
Participants in the intervention group will listen to old songs embedded with 10-Hz alpha-frequency binaural beats through headphones once daily for 30 minutes for 14 consecutive days.
The old songs will be selected according to older adults' music preferences.
|
|
Active Comparator: Old Songs Group
Participants will listen to the same type of old songs without binaural beats through headphones once daily for 30 minutes for 14 consecutive days.
|
Participants in the control group will listen to old songs without binaural beats through headphones once daily for 30 minutes for 14 consecutive days.
The old songs will be selected according to older adults' music preferences.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Montreal Cognitive Assessment Score
Time Frame: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
Cognitive function will be assessed using the Montreal Cognitive Assessment.
The total score ranges from 0 to 30, with higher scores indicating better cognitive function.
|
Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
|
Change in Digit Span Test Score
Time Frame: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
|
|
Change in Stroop Color-Word Test Score
Time Frame: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
|
|
Change in Trail Making Test Score
Time Frame: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
|
|
Change in Pittsburgh Sleep Quality Index Score
Time Frame: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
|
|
Change in Geriatric Anxiety Scale Score
Time Frame: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
|
|
Change in Geriatric Depression Scale-15 Score
Time Frame: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 20, 2026
Study Registration Dates
First Submitted
July 27, 2026
First Submitted That Met QC Criteria
July 27, 2026
First Posted (Actual)
July 30, 2026
Study Record Updates
Last Update Posted (Actual)
July 30, 2026
Last Update Submitted That Met QC Criteria
July 27, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Lunshen [2025] 239
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.